Respiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
31 Dec 2024
Historique:
medline: 20 8 2024
pubmed: 20 8 2024
entrez: 20 8 2024
Statut: ppublish

Résumé

Respiratory syncytial virus (RSV) is an important cause of respiratory illness. While most attention is paid to childhood infection, the RSV burden in adults ≥60 y should also be considered. In Brazil, this is generally underrecognized, where greater focus is toward other respiratory pathogens. This article presents insights from a multidisciplinary panel gathered to review epidemiologic data and current diagnostic approaches to RSV in Brazil (and their limitations) and develop communication strategies to improve knowledge and awareness. National surveillance data indicate a steady increase in cases of RSV-related severe acute respiratory illness (RSV-SARI) in those aged ≥60 y in recent years, with high fatality rates (>30%). Routine RSV testing in older individuals with respiratory symptoms is relatively low. Educational activities targeted toward health-care professionals and the general public are critical to raising awareness of the importance of RSV in older individuals, particularly as protective vaccines are now available.

Identifiants

pubmed: 39161095
doi: 10.1080/21645515.2024.2388943
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2388943

Auteurs

Nancy Bellei (N)

Laboratório de Virologia Clínica, Universidade Federal de São Paulo (UNIFESP), Escola Paulista de Medicina (EPM), Disciplina de Infectologia, São Paulo, Brazil.

Marcelo Ferreira da Costa Gomes (M)

Programa de Computação Científica (PROCC), Fiocruz, Presidência, Rio de Janeiro, Brazil.

Sonia M Raboni (SM)

Molecular Virology Research Laboratory, Universidade Federal do Paraná, Curitiba, Brazil.

Maisa Kairalla (M)

Universidade Federal de Sao Paulo, Sao Paulo, Brazil.

Ricardo Amorim Correa (RA)

Departamento de Clínica Médica, Serviço de Pneumologia, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Monica Levi (M)

Sociedade Brasileira de Imunizações (SBim), São Paulo, Brazil.

Alberto Chebabo (A)

Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.

Isabela Ballalai (I)

Sociedade Brasileira de Imunizações (SBim), Rio de Janeiro, Brazil.

Sergio Cimerman (S)

Sociedade Brasileira de Imunizações (SBim), São Paulo, Brazil.
Instituto de Infectologia Emílio Ribas, São Paulo, Brazil.
Universidade Paulista (UNIP) - Campus Alphaville, São Paulo, Brazil.

Cecilia M Roteli-Martins (CM)

Faculdade de Medicina do ABC, Santo André, Brazil.

Susana Aidé (S)

Maternal and Child Department, Faculty of Medicine, Universidade Federal Fluminense, Rio de Janeiro, Brazil.

Margareth P Dalcolmo (MP)

Centro de Referência Helio Fraga, Fiocruz, Rio de Janeiro, Brazil.

Renato De Ávila Kfouri (R)

Universidade Federal de Sao Paulo, Sao Paulo, Brazil.
Sociedade Brasileira de Imunizações (SBim), São Paulo, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH